Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
7 p, 1018.1 KB Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients / Sadovnick, A. Dessa (Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Traboulsee, Anthony L. (Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Bernales, Cecily Q. (Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Ross, Jay P. (Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Forwell, Amanda L. (Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Yee, Irene M. (Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Guillot-Noel, Lena (Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France) ; Fontaine, Bertrand (Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France) ; Cournu-Rebeix, Isabelle (Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, France) ; Alcina, Antonio (Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, 18100 Granada, Spain) ; Fedetz, Maria (Unidad de Esclerosis Múltiple, Hospital Universitario Virgen Macarena, 41071 Sevilla, Spain) ; Izquierdo, Guillermo (Unidad de Esclerosis Múltiple, Hospital Universitario Virgen Macarena, 41071 Sevilla, Spain) ; Matesanz, Fuencisla (Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, 18100 Granada, Spain) ; Hilven, Kelly (Laboratory for Neuroimmunology, Neurosciences, University of Leuven, 1022, Belgium) ; Dubois, Bénédicte (Department of Neurology, University Hospitals Leuven, University of Leuven, Belgium) ; Goris, An (Laboratory for Neuroimmunology, Neurosciences, University of Leuven, 1022, Belgium) ; Astobiza, Ianire (Achucarro Basque Center for Neuroscience, 48170 Spain) ; Alloza, Iraide (IKERBASQUE, Basque Foundation for Science, 48011 Spain) ; Antigüedad, Alfredo (Servicio de Neurología, Hospital Universitario Basurto-Osakidetza, 48940 Bilbao, Spain) ; Vandenbroeck, Koen (IKERBASQUE, Basque Foundation for Science, 48011 Spain) ; Akkad, Denis A. (Department of Human Genetics, Ruhr University, 44801 Bochum, Germany) ; Aktas, Orhan (Department of Neurology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany) ; Blaschke, Paul (Department of Neurology, University of Rostock, 18059 Germany) ; Buttmann, Mathias (Department of Neurology, University of Würzburg, 97080 Würzburg, Germany) ; Chan, Andrew (Department of Neurology, University Hospital Bern and University of Bern, 3010 Bern, Switzerland) ; Epplen, Joerg T. (Department of Human Genetics, Ruhr University, 44801 Bochum, Germany) ; Gerdes, Lisa-Ann (Institute for Clinical Neuroimmunology, Ludwig Maximilian University, 80539 Munich, Germany) ; Kroner, Antje (Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI 53226) ; Kubisch, Christian (Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany) ; Kümpfel, Tania (Institute for Clinical Neuroimmunology, Ludwig Maximilian University, 80539 Munich, Germany) ; Lohse, Peter (Institute of Laboratory Medicine and Human Genetics, 78224 Singen, Germany) ; Rieckmann, Peter (Department of Neurology, Sozialstiftung Bamberg Hospital, 96049 Germany) ; Zettl, Uwe K. (Department of Neurology, University of Rostock, 18059 Germany) ; Zipp, Frauke (Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg-University Mainz, 55122 Germany) ; Bertram, Lars (School of Public Health, Medicine, Imperial College London, SW7 2AZ, UK) ; Lill, Christina M (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernandez, Oscar (Department of Neurology, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain) ; Urbaneja, Patricia (Department of Neurology, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain) ; Leyva, Laura (Research Laboratory, UGC Neurociencias Clínicas. IBIMA-Hospital Regional Universitario de Málaga, 29010 Spain) ; Alvarez-Cermeño, Jose Carlos (Immunology and Neurology Service, Multiple Sclerosis Unit, Ramón y Cajal University Hospital-IRYCIS, 28034 Madrid, Spain) ; Arroyo, Rafael (Department of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, 28040 Madrid, Spain) ; Garagorri, Aroa M. (Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain) ; García-Martínez, Angel (Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain) ; Villar, Luisa M. (Immunology and Neurology Service, Multiple Sclerosis Unit, Ramón y Cajal University Hospital-IRYCIS, 28034 Madrid, Spain) ; Urcelay, Elena (Department of Immunology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos-IdISSC, Madrid, Spain) ; Malhotra, Sunny (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Berger, Thomas (Department of Clinical Neurology, Medical University of Innsbruck, 6020 Austria) ; Fazekas, Franz (Department of Neurology, Medical University of Graz, 8010 Austria) ; Reindl, Markus (Department of Clinical Neurology, Medical University of Innsbruck, 6020 Austria) ; Schmied, Mascha C. (Department of Neurology, Medical University of Vienna, 1090 Austria) ; Zimprich, Alexander (Department of Neurology, Medical University of Vienna, 1090 Austria) ; Vilariño-Güell, Carles (Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada) ; Universitat Autònoma de Barcelona
Multiple sclerosis (MS) is a prevalent neurological disease of complex etiology. Here, we describe the characterization of a multi-incident MS family that nominated a rare missense variant (p. G420D) in plasminogen (PLG) as a putative genetic risk factor for MS. [...]
2016 - 10.1534/g3.116.030841
G3, enomes  
2.
5 p, 320.8 KB Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles / de la Hera, Belén (Hospital Clínico San Carlos (IdISSC), Madrid) ; Urcelay, Elena (Hopital Purpan, Toulouse,) ; Brassat, David (Ruhr University, Bochum) ; Chan, Andrew ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Salmen, Anke (St. Josef-Hospital) ; Villar, Luisa Maria (Hospital Universitario Ramón y Cajal) ; Álvarez-Cermeño, José Carlos (Hospital Universitario Ramón y Cajal) ; Izquierdo, Guillermo (Hospital Universitario Virgen Macarena) ; Fernández, Oscar (Hospital Universitario Regional de Málaga,) ; Oliver, Begoña (Instituto de Biomedicina de Málaga (IBIMA)) ; Saiz, Albert (Hospital Clínic de Barcelona) ; Ara, Jose Ramón (Universidad de Zaragoza) ; Vigo, Ana G. ; Arroyo, Rafael ; Meca, Virginia (Hospital Universitario de la Princesa) ; Malhotra, Sunny (Hospital Universitari Vall d'Hebron) ; Fissolo, Nicolás (Hospital Universitari Vall d'Hebron) ; Horga, Alejandro ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
We aimed to investigate potential associations between human leukocyte antigen (HLA) class I and class II alleles and the development of anaphylactic/anaphylactoid reactions in patients with multiple sclerosis (MS) treated with natalizumab. [...]
2014 - 10.1212/NXI.0000000000000047
Neurology® neuroimmunology & neuroinflammation, Vol. 1 (december 2014)  
3.
9 p, 542.1 KB Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis / Cantó, Ester (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar ; Villar, Luisa Maria (Hospital Ramón y Cajal. Departamento de Neurología) ; Borrás, Eva (Universitat Pompeu Fabra (UPF). Proteomics Unit) ; Álvarez-Cermeño, Jose Carlos (Hospital Ramón y Cajal. Departamento de Neurología) ; Chiva, Cristina (Pniversitat Pompeu Fabra (UPF). Proteomics Unit) ; Sabidó, Eduard (Universitat Pompeu Fabra (UPF). Proteomics Unit) ; Rovira, Alex (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Unitat de Neuroimmunologia Clínica) ; Universitat Autònoma de Barcelona
In a previous proteomics study using pooled cerebrospinal fluid (CSF) samples, we proposed apolipoprotein AI, apolipoprotein AIV, vitronectin, plasminogen, semaphorin 7A, and ala-β-his-dipeptidase as candidate biomarkers associated with the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndromes (CIS). [...]
2014 - 10.1186/s12974-014-0181-8
Journal of neuroinflammation, Vol. 11 (november 2014)  

Vea también: autores con nombres similares
1 Alvarez-Cermeño, JC
2 Alvarez-Cermeño, Jose C.
3 Alvarez-Cermeño, Jose Carlos
2 Alvarez-Cermeño, José C.
1 Álvarez-Cermeño, J.C.
3 Álvarez-Cermeño, José Carlos
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.